Related Experiment Video
Updated: Jun 27, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
On the track of mesothelial progenitor cells from the peritoneal cavity transplanted to immunodeficient mice
Seyed Adel Moallem1, Leila Jahangiri
1Department of Pharmacodynamy and Toxicology, School of Pharmacy, Pharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract:
Mesothelial progenitor cells have been reported to reside in either the monolayer of mesothelium, submesothelium or within the peritoneal cavity as free floating cells. As a putative plasticity has been reported for the mesothelial progenitor cells and considering the potential implications of the establishment of a novel resource of stem/progenitor cells in gene and cell therapeutics and tissue engineering, we conducted an in vivo tracking of transplanted mesothelial cells. In order to induce immunodeficiency, the recipient mice were treated with 32 mg kg(-1) of daily Cyclosporine. On days 14, 30 and 60 post transplantation, brain, heart, skeletal muscle and lung tissues were screened by a modified FISH method directed to the Y chromosome of donor cells. Fluorescence harboring cells were analyzed by flow cytometry and fluorescent microscopy. The data confirmed by PCR, demonstrated the existence morphology alteration of the donor cells in various organs of the recipient mice, notably in the skeletal muscle and lung and less in the heart and brain. Immunostaining of recovered cells from the nervous recipient tissues suggests differentiation of mesothelial cells in the new microenvironment.
Insights
Transplanted mesothelial progenitor cells showed plasticity, migrating and altering morphology in various organs. These findings suggest potential for stem cell therapeutics and tissue engineering applications.
Area of Science:
- Regenerative Medicine
- Cell Biology
Background:
- Mesothelial progenitor cells (MPCs) are found in mesothelium and peritoneal cavity.
- MPCs exhibit plasticity, offering potential for cell and gene therapies and tissue engineering.
Purpose of the Study:
- To track transplanted mesothelial cells in vivo.
- To investigate the potential of mesothelial cells in regenerative medicine.
Main Methods:
- Transplanted mesothelial cells into immunodeficient mice treated with Cyclosporine.
- Utilized modified FISH for Y chromosome detection in recipient tissues (brain, heart, skeletal muscle, lung).
- Analyzed cells via flow cytometry, fluorescent microscopy, and PCR.
Main Results:
- Confirmed donor cell presence and morphology alteration in recipient organs, particularly skeletal muscle and lung.
- Observed less alteration in heart and brain tissues.
- Immunostaining suggested mesothelial cell differentiation in neural tissues.
Conclusions:
- Transplanted mesothelial cells demonstrate in vivo plasticity and migration capabilities.
- Evidence supports mesothelial cells' potential for differentiation and therapeutic applications in tissue engineering and regenerative medicine.

